CN¥ 8.4
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly overvalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Shanghai Shen Lian Biomedical Corporation operates within China's animal health industry, specializing in the entire lifecycle of veterinary biological products, from initial research and development to manufacturing and sales. A primary focus for the company is the creation of advanced synthetic peptide vaccines, specifically engineered to combat foot-and-mouth disease. This enterprise was established in 2001 and is based in Shanghai, China.
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. Specifically, the stock is overvalued on EV/EBITDA.
Data is available to registered users only